Celemics Inc
Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It als… Read more
Market Cap & Net Worth: Celemics Inc (331920)
Celemics Inc (KQ:331920) has a market capitalization of $38.19 Million (₩55.92 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #23357 globally and #1253 in its home market, demonstrating a 28.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Celemics Inc's stock price ₩6850.00 by its total outstanding shares 8164148 (8.16 Million).
Celemics Inc Market Cap History: 2020 to 2026
Celemics Inc's market capitalization history from 2020 to 2026. Data shows change from $150.55 Million to $38.19 Million (-21.18% CAGR).
Index Memberships
Celemics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.02% | #610 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.02% | #610 of 1384 |
Weight: Celemics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Celemics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Celemics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Celemics Inc's market cap is 0.00 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
Celemics Inc's market cap is 0.00 times its annual earnings
1.95x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $150.55 Million | $5.27 Billion | -$4.71 Billion | 0.03x | N/A |
| 2021 | $85.59 Million | $8.08 Billion | -$5.24 Billion | 0.01x | N/A |
| 2022 | $32.34 Million | $8.73 Billion | -$4.80 Billion | 0.00x | N/A |
| 2023 | $23.59 Million | $6.58 Billion | -$3.88 Billion | 0.00x | N/A |
| 2024 | $18.26 Million | $6.72 Billion | $12.27 Billion | 0.00x | 0.00x |
Competitor Companies of 331920 by Market Capitalization
Companies near Celemics Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Celemics Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Celemics Inc Historical Marketcap From 2020 to 2026
Between 2020 and today, Celemics Inc's market cap moved from $150.55 Million to $ 38.19 Million, with a yearly change of -21.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩38.19 Million | +152.30% |
| 2025 | ₩15.14 Million | -17.10% |
| 2024 | ₩18.26 Million | -22.58% |
| 2023 | ₩23.59 Million | -27.07% |
| 2022 | ₩32.34 Million | -62.21% |
| 2021 | ₩85.59 Million | -43.15% |
| 2020 | ₩150.55 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Celemics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.19 Million USD |
| MoneyControl | $38.19 Million USD |
| MarketWatch | $38.19 Million USD |
| marketcap.company | $38.19 Million USD |
| Reuters | $38.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.